Form 4: Dexcom Director Transfers Shares to Revocable Trust
SEC Form 4 Filing
Director Richard Alexander Collins transferred shares of Dexcom Inc. common stock to the Richard A. Collins Revocable Trust on May 18, 2024.
Summary
- On May 18, 2024, Richard Alexander Collins, a director of Dexcom Inc., transferred 2,906 shares of Dexcom common stock from direct ownership to the Richard A. Collins Revocable Trust.
- The transfer occurred upon the vesting of previously awarded restricted stock units.
- Following the transaction, Collins directly owns no shares and indirectly owns 39,310 shares through the trust.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a share transfer, indicating a neutral sentiment.
Industry Context
This is a routine disclosure related to executive compensation and personal financial planning, common among publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 05/18/2024 | Date of share transfer to the Richard A. Collins Revocable Trust |
| 05/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.